2024-11-22210 Pages3680 USD
Lung cancer liquid biopsy is a non-invasive diagnostic test that involves analyzing biomarkers, such as circulating tumor cells, cell-free DNA, and exosomes, in a patient's blood sample to detect the presence of lung cancer. This innovative approach enables healthcare providers to identify specific genetic mutations associated with lung cancer, monitor disease progression, and personalize treatment plans for patients. By providing a less invasive alternative to traditional tissue biopsies, lung cancer liquid biopsy offers a promising solution for early detection and precision medicine in the management of lung cancer.
The market for lung cancer liquid biopsy is experiencing significant growth driven by several key factors. Firstly, the rising incidence of lung cancer globally, coupled wit